- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:42 | Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved | 1 | Benzinga.com | ||
| POLYRIZON Aktie jetzt für 0€ handeln | |||||
| Di | Polyrizon Shares Jump Over 38% After Securing Nasdaq Listing Extension | 2 | RTTNews | ||
| Di | Polyrizon retains Nasdaq listing following hearings panel | 2 | Seeking Alpha | ||
| Di | Polyrizon secures continued Nasdaq listing after panel hearing | 2 | Investing.com | ||
| Di | Polyrizon sichert sich nach Anhörung Verbleib an der NASDAQ | 2 | Investing.com Deutsch | ||
| Di | Polyrizon Ltd.: Polyrizon Retains Nasdaq Listing Following Hearings Panel | 84 | GlobeNewswire (Europe) | Raanana, Israel, July 15, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal... ► Artikel lesen | |
| Di | Polyrizon Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.06. | Polyrizon-Direktor Omer Srugo tritt zurück; Vorstand bestätigt unabhängige Mitglieder | 1 | Investing.com Deutsch | ||
| 30.06. | Polyrizon Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.06. | Polyrizon Ltd.: Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics | 1 | GlobeNewswire (USA) | ||
| 12.06. | Polyrizon Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | Pre-market Movers: Zeo Energy, Elong Power, Brooge Energy, NanoVibronix, Polyrizon | 521 | AFX News | OVERLAND PARK (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).In the Green Zeo Energy Corp. (ZEO) is up over 121% at... ► Artikel lesen | |
| 23.05. | Polyrizon recives Nasdaq delisting notice | 6 | Seeking Alpha | ||
| 23.05. | Polyrizon faces Nasdaq delisting over shareholder dilution | 1 | Investing.com | ||
| 23.05. | Polyrizon Ltd.: Polyrizon Announces Receipt of Nasdaq Delisting Notice | 315 | GlobeNewswire (Europe) | Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal... ► Artikel lesen | |
| 22.05. | Polyrizon Ltd. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| 21.05. | Polyrizon Announces Encouraging Preclinical Data On Nasal Protection Platform | 1 | RTTNews | ||
| 21.05. | Polyrizon Ltd.: Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform | 1 | GlobeNewswire (USA) | ||
| 14.05. | Polyrizon Ltd. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 13.05. | Polyrizon begins preclinical studies for seizure treatment | 2 | Investing.com |
1 2 3 4 Weiter >>
64 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 41,030 | -0,13 % | Dividendenbekanntmachungen (10.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCENTURE PLC IE00B4BNMY34 1,48 USD 1,2626 EUR AT&T INC US00206R1023 0,2775 USD 0,2367 EUR AZZ INC US0024741045 0,2 USD 0,1706... ► Artikel lesen | |
| NOVAVAX | 5,932 | -0,07 % | Novavax Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| PALATIN TECHNOLOGIES | 0,101 | 0,00 % | Palatin Technologies, Inc.: Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity | Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatment
Combination of oral PL7737 and tirzepatide resulted in additive... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,110 | -2,63 % | Inovio wins new Overweight at Piper Sandler on potential FDA nod for lead drug | ||
| COSCIENS BIOPHARMA | 2,960 | +2,07 % | COSCIENS Biopharma Inc.: COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders | TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) ("COSCIENS" or the "Company"), a life sciences company developing and commercializing a diversified... ► Artikel lesen | |
| XOMA ROYALTY | 22,400 | 0,00 % | ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction | SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC and BOSTON and EMERYVILLE, Calif., July 14, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ:... ► Artikel lesen | |
| T2 BIOSYSTEMS | 0,124 | +98,08 % | NSE/A - T2 Biosystems, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| PHIO PHARMACEUTICALS | 2,395 | 0,00 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort | -Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in fourth cohort, permitting dose escalation in expected final cohortMarlborough, Massachusetts--(Newsfile Corp. -... ► Artikel lesen | |
| MOSAIC IMMUNOENGINEERING | - | - | Mosaic ImmunoEngineering Inc. - 10-Q, Quarterly Report | ||
| ORAGENICS | 1,360 | 0,00 % | Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split | SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company"), a biotech company advancing innovative treatments for brain-related health conditions... ► Artikel lesen | |
| LADRX | - | - | LadRx Corp - 8-K, Current Report | ||
| VIVUS | - | - | Vivus' Qsymia gains market approval in UAE for obesity treatment | ||
| TENAX THERAPEUTICS | 2,770 | -100,00 % | Tenax Therapeutics, Inc.: Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update | Successfully Completed Private Placements with Aggregate Gross Proceeds of Approximately $125 Million to Support Advancement of Two Registrational Studies for TNX-103 in PH-HFpEF and Fund Operations... ► Artikel lesen | |
| WINDTREE THERAPEUTICS | 0,830 | 0,00 % | Pre-market Movers: Global Interactive Technologies, MDB Capital, Empro Group, CapsoVision, Windtree Therapeutics | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.55 A.M. ET).In the Green Global Interactive Technologies, Inc. (GITS) is up... ► Artikel lesen | |
| EDESA BIOTECH | 1,920 | +1,59 % | Edesa Biotech, Inc.: Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results | TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases... ► Artikel lesen |
Das Unternehmen POLYRIZON LTD kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLYRIZON LTD finden Sie auf Wallstreet Online.